NIHR Newcastle In Vitro Diagnostics Co-operative Launched!
The newly established NIHR Newcastle In Vitro Diagnostics (IVD) Co-operative is led by Professor John Simpson, Dean of Translational Research & Professor of Respiratory Medicine, Newcastle University and is built upon the success of the NIHR Diagnostic Evidence Co-operative (DEC) Newcastle between 2013 and 2017.
The role of the Co-operative will be to deliver high quality, robust scientific evidence on the care pathway and economic benefits in vitro diagnostic tests (IVDs) and diagnostic medical devices — i.e. how their adoption by the NHS would benefit patients and provide good value for money.
The Newcastle IVD Co-operative will focus on three areas of important unmet clinical need:
- Infectious diseases (led by Dr Ashley Price),
- Stratified Medicine (led by Professor Nick Reynolds), and
- Ageing and long term chronic conditions (led by Dr James Frith).
Novel technologies in these areas represent huge potential to revolutionise patient, laboratory and work flows within the NHS. However, they require robust scientific testing before widespread introduction.
The evaluation methodologists working within the Newcastle IVD Co-operative are uniquely placed to support commercial and academic technology developers, with their own expertise and ability to link to additional expertise and resources needed for clinical studies available through staff from within the NHS and Newcastle University. Together, we can design and carry out the research required to provide the evidence required by NHS commissioners for investing in the most promising new technologies.
Alongside colleagues within the University and the Trust, we work closely with other infrastructure within the North East such as the NIHR Newcastle Biomedical Research Centre, the NIHR Innovation Observatory, the AHSN North East North Cumbria, MedConNect North, the MRC Molecular Pathology Node, the NICE External Assessment Centre, and the CEPA Biobank.
Dr Louise Wood, Director of Science, Research and Evidence at the Department of Health, said: “The funding received by the 11 NIHR Medtech and In Vitro Diagnostic Co-operatives will make a real difference to patients’ lives and provide a focal point for the medtech and in vitro diagnostic industries to develop new technologies and generate the evidence needed by the NHS to support the uptake of new tests.”
The Newcastle IVD Co-operative is delivered as a partnership between Newcastle upon Tyne Hospitals NHS Foundation Trust and Newcastle University.